EISAI-E2007-G000-208

Study Sponsor: Eisai

Study Title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Explore the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Medicine or Vaccine (generic name)

perampanel

Sponsor Identification Number

E2007-G000-208

Trial Registry Identification Number(#'s)

NCT00416195
EU CTR 2006-003702-26

Medical Condition

Refractory Partial Seizures

Phase

Phase 2

Link to study details on the Eisai Clinical Study Register

not available

Link to study details on ClinicalTrials.gov (if available)

https://www.clinicaltrials.gov/ct2/show/NCT00416195

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003702-26/results

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

No restrictions.

Date Added to this Site

February 2021